Alan

Most health insurers pay claims and get out of the way. Alan started from the opposite idea: that insurance, care, and prevention should live in one app and reinforce each other. Founded in Paris in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin, it became the first company to hold a French insurance license as a fresh entrant in decades, then bolted a virtual clinic and a prevention layer on top.

Ten years in, that bet looks less contrarian. Alan now covers more than 1 million members and 40,000-plus companies across France, Belgium, Spain, and Canada, and passed 785 million euros in annual recurring revenue in 2025. A 100 million euro round in March 2026 put its valuation at 5 billion euros, and the company says it is now profitable in France with the rest of the business closing in on break-even.

Alan sells health insurance the way a software company would: sign up in minutes, no waiting period, and 90% of reimbursements handled within 24 hours straight from your phone. That is the part that pays the bills. What makes it different is what comes bundled with it.

Inside the same app members reach the Alan Clinic (chats and video consults with doctors, physios, dietitians, and psychologists, seven days a week), a prevention layer that turns walking and meditating into games, and an AI medical assistant that answers questions instantly. The pitch to an employer is simple: this is the rare HR benefit that employees actually open. About a third of members are weekly active in the prevention challenges, and the company likes to note that satisfaction runs far above the industry norm.

The French health system Alan sells into is straining in ways members feel every week. Alan cites that 65% of GPs no longer take on new patients as their primary doctor, 45% of French people skipped at least one treatment in 2024 over cost, and the average wait for a dermatologist appointment has stretched to around 95 days.

For employers the bill lands elsewhere: Alan puts the cost of absenteeism and lost productivity at roughly 27,000 euros per employee per year. Its answer is to attack the friction on both sides, instant reimbursements and jargon-free coverage for the member, a dashboard that its clients say takes under two hours a year to manage for HR, and same-day access to a doctor so a sick kid on a Sunday does not mean the emergency room.

The core buyer is the company: startups and SMBs where Alan first won share, mid-market employers, and increasingly larger enterprises like HP and Volkswagen. Alan started in the French tech scene, and roughly a third of its clients now mention the benefit in their own job postings, which tells you how it is used, as a recruiting and retention tool, not just a compliance box.

Beyond employers, Alan sells directly to the self-employed and to retirees through its Dolce Vita offer, and it is moving toward public-sector agents in France. The end user is always the same person though: a member and their family who would rather message a doctor than navigate a waiting list.

Alan's product line reads like an attempt to absorb the whole health journey into a single app. The insurance is the anchor; the Clinic, the prevention game, and an AI companion are what keep members coming back between claims.

The newest and most ambitious piece is Alan Precision, built by the founding team of ARO after Alan acquired the preventive-health startup in 2026. It reads a member's biology, wearables, and medical history together and turns it into a personalized protocol, the kind of deep health check-up that used to cost thousands and stay locked to the few who could pay.

Alan makes its money as a real insurer, not a broker. It holds its own French insurance license, collects premiums, manages the risk with proprietary pricing models, and pays claims, which is why company filings run through Alan Insurance, a regulated societe anonyme supervised by France's ACPR.

Group plans are priced per employee per month and split with the employer, and the model is B2B-first with growing direct offers for the self-employed and retirees. What sets the economics apart is that Alan also delivers care through its Clinic, so prevention and faster treatment are meant to lower the claims it pays, turning a cost line into a lever.

Alan is squeezed between two very different rivals. On one flank sit France's incumbent mutuelles and traditional insurers, slower and more bureaucratic, but entrenched with decades of employer relationships. On the other sit standalone health and wellness apps that offer teleconsultation or prevention but cannot pay a claim.

Alan's argument is that owning both ends is the moat. Because it is the insurer and runs the Clinic, it can connect a reimbursement, a doctor's chat, and a prevention nudge in a way a point solution cannot, and its proprietary AI is built into pricing and claims rather than bolted on. Whether that integration stays ahead as bigger insurers digitize is the open question.

The traction is concrete for a company still chasing break-even. More than 1 million members and over 40,000 companies, 785 million euros in ARR in 2025 up 53% year on year, and operational profitability reached in its home French market.

The product metrics back the story members tell: 90% of reimbursements processed within 24 hours, a 4.9 out of 5 App Store rating, and 98% of SMB clients spending under two hours a year managing coverage. On the care side, Alan says its AI medical assistant draws good-or-excellent ratings from doctors more than 95% of the time, and that half of members who wanted to see a professional no longer needed to after a Clinic conversation.

The recurring praise is consistent across app stores and employee reviews: reimbursements are fast, the app is clear, and having a psychologist or physio a chat away inside your insurance feels genuinely new. Employees rate Alan highly too, with strong marks for autonomy, flexibility, transparent pay, and the fully funded coverage they get themselves.

The criticism is worth taking seriously. Some longtime members say the once-human support has leaned harder on bots and lost a step, and employees flag that Alan's high-performance, radically transparent culture is not for everyone and can tip toward burnout. The company is unusually upfront about the second point, publishing a candid list of what Alan is not.

Alan raised 100 million euros in March 2026 at a 5 billion euro valuation, a round led by existing backer Index Ventures with new money from Greenoaks, Kaaf, and SH, plus angels including Shopify's Tobi Lutke and footballer Antoine Griezmann. That followed a 173 million euro Series F in 2024, led by Belgian bank Belfius, that valued the company at 4.5 billion dollars.

The cap table is heavyweight: Temasek, Coatue, Lakestar, and Ontario Teachers' Pension Plan all sit on it, and the Belfius deal came with a distribution partnership into Belgium. Rather than bank the profitability it has already found in France, Alan is spending to grow, with a stated target of 1 billion euros in ARR in 2026.

Alan has reached the point most insurtechs never do: it makes money in its home market. The interesting choice is what it does with that. Instead of coasting to overall profitability, it is pouring capital into new geographies, into Alan Precision's bet on advanced prevention, and into AI across care and operations, with a target of 1 billion euros in ARR in 2026.

The risk is the same as the ambition. Expanding across Europe and Canada while building a preventive-health product from zero is expensive, and its edge depends on staying more integrated and faster than incumbents who are digitizing too. If the integrated model holds, Alan is one of the few players anywhere combining a real insurance license, care delivery, and a million-plus member base in a single app.

Alan runs on a set of leadership principles it calls a Healthy Business culture: mission is the boss, radical transparency, distributed ownership, and a written-first, async way of working where decisions get documented rather than shouted across a room. Pay follows the same logic, with public salary grids and no negotiation, and every employee gets equity.

The team is more than 800 people across France, Belgium, Spain, and Canada, working hybrid or fully remote with home-office budgets and coworking hubs. Alan is blunt that this is a demanding place, high standards, honest feedback, a lot of autonomy, and openly says it is not the right fit for everyone.

Alan is unusually transparent about pay. Compensation runs off a published salary grid with no negotiation, so roles map to a level band rather than a haggled number, and every permanent employee gets an equity package on top of base. Salaries are in euros across its France, Belgium, and Spain hubs.

Only a couple of Alan's currently disclosed ranges carry hard numbers, so the bands below are a thin sample rather than a full picture. The bigger signal is structural: fair, grid-based base pay plus equity for all, which the company treats as core rather than a perk.

Alan is a French societe anonyme with 203 million euros of paid-up share capital, registered at 117 quai de Valmy, 75010 Paris, and governed by the French Insurance Code (SIREN 818 353 070). The regulated insurance business runs through Alan Insurance, supervised by France's prudential authority, the ACPR, and Alan publishes annual Solvency and Financial Condition Reports.

Data stays in the EU: alan.com is hosted on Amazon Web Services Europe, and the company operates under GDPR with a declared CNIL registration and a data protection officer reachable at privacy@alan.com. Engineering roles reference ISO 27001 and HDS, France's health-data hosting standard, as part of the compliance bar.

Alan's headlines over the past two years track one story: a fast climb in valuation on the back of real revenue growth. The March 2026 round pushed it to 5 billion euros, and the 2024 Series F that put it at 4.5 billion dollars came bundled with a Belgian distribution deal.

The quieter thread is product and profitability, the ARO acquisition that seeded Alan Precision, the push on AI across the Clinic and internal ops, and the claim of operational profitability in France. Together they explain why a health insurer keeps turning up in tech coverage.